Preliminary Program
Stream 3: Frontiers of Clinical Oncology
|
Forum 3-1: Lung Cancer |
|
|
Day 2: Morning, May 12, 2022 |
|
|
Chair |
Dr. Nicolas Paleiron, Respiratory Disease Unit, HIA Sainte Anne, France |
| Co-chair | Call for Co-chair |
|
Time |
Speeches and Speakers |
|
08:30-08:35 |
Chair’s Introduction |
|
08:35-09:00 |
Dr. Acharan S. Narula, Director, Narula Research, USA |
|
09:00-09:25 |
Dr. Alexandru Grigorescu, Professor, Alexandru Trestioreanu Oncology Institute, USA |
|
09:25-09:50 |
Dr. Ralph Alexander Schmid, Professor, Bern University Hospital; University of Bern, Switzerland |
|
09:50-10:15 |
Dr. Nicolas Paleiron, Respiratory Disease Unit, HIA Sainte. Anne, France |
|
10:15-10:30 |
Coffee Break |
|
10:30-10:55 |
Dr. Zhang Weiping, Director, The Third Affiliated Hospital of Zhejiang Chinese Medical University, China |
|
10:55-11:20 |
Speech Opportunity Available |
|
11:20-11:45 |
Speech Opportunity Available |
|
11:45-12:10 |
Speech Opportunity Available |
|
Forum 3-2: Breast Cancer |
|
|
Day 2: Morning, May 12, 2022 |
|
|
Chair |
Call for Chair |
| Co-chair | Call for Co-chair |
|
Time |
Speeches and Speakers |
|
08:30-08:35 |
Chair’s Introduction |
|
08:35-09:00 |
Dr. Ashok Jain, Professor, Albany State University, USA |
|
09:00-09:25 |
Dr. Kris Howard, Technical Director, Florida Cancer Specialists and Research Institute, USA |
|
09:25-09:50 |
Dr. Craig Kukard, Director, Head, Central Coast Cancer Centre; University of Newcastle, Australia |
|
09:50-10:15 |
Dr. Mariette Gerber, Head, Cancer Research Centre of the Cancer Institute in Montpellier, France |
|
10:15-10:30 |
Coffee Break |
|
10:30-10:55 |
Dr. Miri Ziv, Vice Chairman, Israel Cancer Association, Israel |
|
10:55-11:20 |
Dr. Beiyun Chen, Associate Professor, Mayo Clinic, USA |
|
11:20-11:45 |
Title: Targeting CCN5 Activation for TNBC Growth and Metastasis Dr. Sushanta K. Banerjee, VA Medical Center, USA
|
|
11:45-12:10 |
Speech Opportunity Available |
|
Forum 3-3: Brain, Head, Oral and Neck Cancer |
|
|
Day 2: Morning, May 12, 2022 |
|
|
Chair |
Call for Chair |
| Co-chair | Call for Co-chair |
|
Time |
Speeches and Speakers |
|
08:30-08:35 |
Chair’s Introduction |
|
08:35-09:00 |
Speech Opportunity Available |
|
09:00-09:25 |
Title: TBD Dr. Avi Zini, Vice Dean, Faculty of Dental Medicine, Hebrew University, Israel
|
|
09:25-09:50 |
Title: New Analogue of Curcuma ( PAC) and It Potential Preclinical Application for Oral Cancer Therapy Dr. Abdelhabib Semlali, Professor, Laval University, Canada
|
|
09:50-10:15 |
Title: TBD Dr. Terry Lichtor, Associate Professor, Rush University Medical Center, USA
|
|
10:15-10:30 |
Coffee Break |
| 10:30-10:55 | Speech Opportunity Available |
| 10:55-11:20 | Speech Opportunity Available |
| 11:20-11:45 | Speech Opportunity Available |
| 11:45-12:10 | Speech Opportunity Available |
|
Forum 3-4: GI Cancers: Gastroesophageal, Pancreatic, Hepatobiliary, Colorectal, and Anal Cancers |
|
|
Day 2: Morning, May 12, 2022 |
|
|
Chair |
Dr. Mingliang He, Professor, City University of Hong Kong, China
|
| Co-chair |
|
|
Time |
Speeches and Speakers |
|
08:30-08:35 |
Chair’s Introduction |
|
08:35-09:00 |
Title: TBD Dr. Sabino Zani, Surgical Oncologist, Davis Ambulatory Surgical Center, Duke University Medical Center, USA
|
|
09:00-09:25 |
Title: Colon Cancer: the Roles of Gut Microbiota Dr. Jun Yu, Professor, Department of Medicine and Therapeutics, Faculty of Medicine at The Chinese University of Hong Kong, China
|
|
09:25-09:50 |
Title: Dimethyl Fumarate is Repurposed as an Alternative Drug for Treating Hepatocellular Carcinoma Dr. Mingliang He, Professor, City University of Hong Kong, China
|
|
09:50-10:15 |
Title: Immunotherapy and the Management of Colorectal Liver Metastases
|
|
10:15-10:30 |
Coffee Break |
|
10:30-10:55 |
Title: TBD Dr. Luciano Tracia, Director, Advanced Technologies "G. Ingrassia", University of Catania, Italy
|
|
10:55-11:20 |
Title: TBD Dr. Antonio Cubillo, Head of the Department of Medical Oncology, the Centro Integral Oncológico Clara Campal,Spain
|
|
11:20-11:45 |
Title: TBD Dr. Khosrow Kashfi, Associate Professor, City University of New York School of Medicine, USA
|
|
11:45-12:10 |
Speech Opportunity Available |
|
Forum 3-5: Liver Cancer |
|
|
Day 2: Afternoon, May 12, 2022 |
|
|
Chair |
Call for Chair |
| Co-chair | Call for Co-chair |
|
Time |
Speeches and Speakers |
|
13:30-13:35 |
Chair’s Introduction |
|
13:35-14:05 |
Dr. Ahmet Gurakar, Medical Director of Liver Transplantation, The Johns Hopkins University, USA |
|
14:05-14:30 |
Dr. Mark Gorrell, Professor, The University of Sydney, Australia |
|
14:30-14:55 |
Dr. Jiancheng Tu, Professor, Zhongnan Hospital of Wuhan University, China |
|
14:55-15:20 |
Speech Opportunity Available |
|
15:20-15:35 |
Coffee Break |
| 15:35-16:00 | Speech Opportunity Available |
| 16:00-16:25 | Speech Opportunity Available |
| 16:25-16:50 | Speech Opportunity Available |
| 16:50-17:15 | Speech Opportunity Available |
|
Forum 3-6: Genitourinary, Kidney, Bladder, Prostate, Testicular, and Penile Cancers |
|
|
Day 2: Afternoon, May 12, 2022 |
|
|
Chair |
Call for Chair |
| Co-chair | Call for Co-chair |
|
Time |
Speeches and Speakers |
|
13:30-13:35 |
Chair’s Introduction |
|
13:35-14:05 |
Title: TBD Dr. Tom Blundell, Professor, University of Cambridge, UK
|
|
14:05-14:30 |
Title: Molecular Classification of Aggressive Bladder Cancer Histologic Variants Dr. Charles C. Guo, Professor of Pathology, University of Texas MD Anderson Cancer Center, USA
|
|
14:30-14:55 |
Title: TBD Dr. Anita K Patel, Program Director, Henry Ford Health System, USA
|
|
14:55-15:20 |
Title: Anticancer Effects of New Peptide HS1001 Targeted on hTERT in Prostate Cancer Cells Dr. Hyung Sik Kim, Professor, Department of Pharmacy, Sungkyunkwan University, Korea
|
|
15:20-15:35 |
Coffee Break |
| 15:35-16:00 |
Title: The Androgen Receptor/Filamin a Complex as a Playmaker in Prostate Cancer-associated fibroblasts(CAFs) Dr. Marzia Di Donato, Department of Precision Medicine, University of Campania 'L. Vanvitelli'- Via L. De Crecchio, Italy (Video Presentation)
|
| 16:00-16:25 | Speech Opportunity Available |
| 16:25-16:50 | Speech Opportunity Available |
| 16:50-17:15 | Speech Opportunity Available |
|
Forum 3-7: Gastrointestinal Cancer |
|
|
Day 2: Afternoon, May 12, 2022 |
|
|
Chair |
Call for Chair |
| Co-chair | Call for Co-chair |
|
Time |
Speeches and Speakers |
|
13:30-13:35 |
Chair’s Introduction |
|
13:35-14:05 |
Speech Opportunity Available |
|
14:05-14:30 |
Speech Opportunity Available |
|
14:30-14:55 |
Speech Opportunity Available |
|
14:55-15:20 |
Title: TBD Dr. Fang-fang Liu, Associate Professor, Peking University, China
|
|
15:20-15:35 |
Coffee Break |
| 15:35-16:00 | Speech Opportunity Available |
| 16:00-16:25 | Speech Opportunity Available |
| 16:25-16:50 | Speech Opportunity Available |
| 16:50-17:15 | Speech Opportunity Available |
|
Forum 3-8: Gynecologic Cancer |
|
|
Day 2: Afternoon, May 12, 2022 |
|
|
Chair |
Call for Chair |
| Co-chair | Call for Co-chair |
|
Time |
Speeches and Speakers |
|
13:30-13:35 |
Chair’s Introduction |
|
13:35-14:05 |
Title: TBD Dr. Hooman Soleymani Majd, Consultant, Oxford University Hospitals NHS Trust, UK
|
|
14:05-14:30 |
Title: Management of Uterine Leiomyosarcoma: Status of Art and Perspectives of Clinical Research Dr. Angiolo Gadducci, Professor, University of Pisa, Italy
|
|
14:30-14:55 |
Title: TBD Dr. Ronit Abir, Professor, Tel Aviv University, Israel
|
|
14:55-15:20 |
Title: Compound 3K, a Specific Pyruvate Kinase M2 Inhibitor, Induces Autophagic Cell Death through the Disruption of the Glycolytic Pathway in Ovarian Cancer Cells
|
|
15:20-15:35 |
Coffee Break |
| 15:35-16:00 | Speech Opportunity Available |
| 16:00-16:25 | Speech Opportunity Available |
| 16:25-16:50 | Speech Opportunity Available |
| 16:50-17:15 | Speech Opportunity Available |
|
Forum 3-9: Hematologic Malignancies |
|
|
Day 3: Morning, May 13, 2022 |
|
|
Chair |
Call for Chair |
| Co-chair | Call for Co-chair |
|
Time |
Speeches and Speakers |
|
08:30-08:35 |
Chair’s Introduction |
|
08:35-09:00 |
Speech Opportunity Available |
|
09:00-09:25 |
Title: TBD Dr. Douglas W. Sborov, Director, Huntsman Cancer Institute, University of Utah, USA
|
|
09:25-09:50 |
Title: TBD Dr. Hakan Brorson, Adjunct Professor, Lund University Cancer Center, Sweden
|
|
09:50-10:15 |
Title: TBD Dr. Nobuyoshi Arima, Director, Shinko Hospital; Medical Research Institute Kitano Hospital, Japan
|
|
10:15-10:30 |
Coffee Break |
|
10:30-10:55 |
Title: TBD Dr. Bunyamin Isik, Director, Hacettepe University, Turkey
|
|
10:55-11:20 |
Title: TBD Dr. Changying Jiang, Assistant Professor, Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, USA
|
|
11:20-11:45 |
Title: Minimal Residual Disease Detection in Acute Leukemia: Clinical Significance and Technical Challenges Dr. Weijie Li, Assistant Professor, Children's Mercy Hospitals and Clinics, USA
|
|
11:45-12:10 |
Speech Opportunity Available |
|
Forum 3-10: Melanoma/Skin Cancers and Sarcoma |
|
|
Day 3: Morning, May 13, 2022 |
|
|
Chair |
Call for Chair |
| Co-chair | Call for Co-chair |
|
Time |
Speeches and Speakers |
|
08:30-08:35 |
Chair’s Introduction |
|
08:35-09:00 |
Dr. Daniel Mark Siegel, Clinical Professor of Dermatology, SUNY Downstate Health Sciences University, USA |
|
09:00-09:25 |
Dr. Athanasios Tsianakas, Director, Klinik für Dermatologie und Allergologie, Fachklinik Bad Bentheim, Germany |
|
09:25-09:50 |
Speech Opportunity Available |
|
09:50-10:15 |
Dr. Navin Kumar Verma, Assistant Professor, Nanyang Technological University, Singapore |
|
10:15-10:30 |
Coffee Break |
| 10:30-10:55 | Speech Opportunity Available |
| 10:55-11:20 | Speech Opportunity Available |
| 11:20-11:45 | Speech Opportunity Available |
| 11:45-12:10 | Speech Opportunity Available |
|
Forum 3-11: Pediatric Oncology |
|
|
Day 3: Morning, May 13, 2022 |
|
|
Chair |
Call for Chair |
| Co-chair | Call for Co-chair |
|
Time |
Speeches and Speakers |
|
08:30-08:35 |
Chair’s Introduction |
|
08:35-09:00 |
Speech Opportunity Available |
|
09:00-09:25 |
Speech Opportunity Available |
|
09:25-09:50 |
Speech Opportunity Available |
|
09:50-10:15 |
Speech Opportunity Available |
|
10:15-10:30 |
Coffee Break |
| 10:30-10:55 | Speech Opportunity Available |
| 10:55-11:20 | Speech Opportunity Available |
| 11:20-11:45 | Speech Opportunity Available |
| 11:45-12:10 | Speech Opportunity Available |
|
Forum 3-12: Geriatric Oncology |
|
|
Day 3: Morning, May 13, 2022 |
|
|
Chair |
Call for Chair |
| Co-chair | Call for Co-chair |
|
Time |
Speeches and Speakers |
|
08:30-08:35 |
Chair’s Introduction |
|
08:35-09:00 |
Title: TBD Dr. Najia Musolino, Chief Executive Officer, International Society of Geriatric Oncology, Switzerland
|
|
09:00-09:25 |
Speech Opportunity Available |
|
09:25-09:50 |
Speech Opportunity Available |
|
09:50-10:15 |
Speech Opportunity Available |
|
10:15-10:30 |
Coffee Break |
| 10:30-10:55 | Speech Opportunity Available |
| 10:55-11:20 | Speech Opportunity Available |
| 11:20-11:45 | Speech Opportunity Available |
| 11:45-12:10 | Speech Opportunity Available |
|
Forum 3-13: Bone Cancer |
|
|
Day 3: Afternoon, May 13, 2022 |
|
|
Chair |
Call for Chair |
| Co-chair | Call for Co-chair |
|
Time |
Speeches and Speakers |
|
13:30-13:35 |
Chair’s Introduction |
|
13:35-14:05 |
Speech Opportunity Available |
|
14:05-14:30 |
Speech Opportunity Available |
|
14:30-14:55 |
Speech Opportunity Available |
|
14:55-15:20 |
Speech Opportunity Available |
|
15:20-15:35 |
Coffee Break |
| 15:35-16:00 | Speech Opportunity Available |
| 16:00-16:25 | Speech Opportunity Available |
| 16:25-16:50 | Speech Opportunity Available |
| 16:50-17:15 | Speech Opportunity Available |
|
Forum 3-14: Care Delivery and Regulatory Policy |
|
|
Day 3: Afternoon, May 13, 2022 |
|
|
Chair |
Call for Chair |
| Co-chair | Call for Co-chair |
|
Time |
Speeches and Speakers |
|
13:30-13:35 |
Chair’s Introduction |
|
13:35-14:05 |
Speech Opportunity Available |
|
14:05-14:30 |
Title: TBD Dr. Yuchan Li, Professor, National Taipei University of Nursing and Health Sciences, Taiwan
|
|
14:30-14:55 |
Title: Hushed Voices and Private Spaces: Fortifying the Role of Qualitative Methodologies in Cancer Research Dr. Maria Minerva P Calimag, Professor, University of Santo Tomas Philippine
|
|
14:55-15:20 |
Speech Opportunity Available |
|
15:20-15:35 |
Coffee Break |
| 15:35-16:00 | Speech Opportunity Available |
| 16:00-16:25 | Speech Opportunity Available |
| 16:25-16:50 | Speech Opportunity Available |
| 16:50-17:15 | Speech Opportunity Available |
Contact Us: Email:Mandy@bitcongress.com
Company Name: 3F, Building 2, Dalian Life Science Innovation Center, 43 Huoju Road,
Hi-tech Industrial Zone, Dalian City, Liaoning Province, China
Copyright © 2008-2022 BIT Congress